Study looks at convenient once-weekly GLP-1 that can reduce chances of heart attacks and strokes.Read More »
Recommendations place special emphasis on youth newly diagnosed with diabetes.Read More »
By Sheri R. Colberg, PhD, FACSM As discussed in an earlier column this year (June 2018), many insulin users have chosen to go “low-carb” to better manage diabetes, which may or may not impact how well they perform in athletic events. How do many athletes with diabetes who swear by …Read More »
What is your top concern when prescribing SGLT-2 inhibitors to patients with diabetes?
- Amputation risk
- Infection risk
- Kidney risk
Follow the link and see how you compare to your colleagues.Read More »
Which of the following is an important consideration when giving a post-meal insulin bolus with the aid of CGM-based trend arrows dosing in order to avoid hypoglycemia in persons using multiple daily insulin therapy?
A. Always consider using the full dose suggested by calculations based on the correction factor and target glucose.
B. Give ~50% of the calculated insulin dose (using the correction factor and target glucose) to adjust for active insulin (insulin on board).
C. Use ~25% of the calculated insulin dose (using the correction factor and target glucose) to adjust for active insulin (insulin on board).
D. Use 75% of the calculated insulin dose (using the correction factor and target glucose) to adjust for active insulin (insulin on board).
E. Another insulin dose should never be given after eating.
Follow the link for the answer.Read More »
When a patient is prescribed a timed-release medication such as Glucotrol XL or Glucophage XR, clinicians need to ensure that the patients understand that they should not crush, chew, or cut these pills. The medications must be swallowed whole.Read More »
Michael S. Irwig, MD, F.A.C.E., is board-certified in Endocrinology & Metabolism and is an associate professor of Medicine at The George Washington University School of Medicine & Health Sciences. He also is an adjunct associate professor of Medicine at Georgetown University School of Medicine.Read More »
In this week's Homerun Slides, we begin a new series showing the value of continuous glucose monitoring.Read More »
The effects are consistent with a role for O-GlcNAc in damping acute hormone- and phosphorylation-mediated signals in situations of chronic nutrient excess. Although discovered in the context of diabetes, the aforementioned changes mediated by the HBP can also be viewed as adaptive responses to excess nutrient flux: muscle cells protect themselves from excess glucose fluxes and the excess nutrients are eventually stored as fat. Indeed, if insulin signaling were not dampened and glycogen synthesis were effectively engaged even with overeating, a pound of ingested carbohydrate would result in approximately four pounds of hydrated glycogen in muscle, and it is easy to visualize diets rich in sodas and donuts resulting in the development of glycogen storage diseases.Read More »
In this Exclusive Interview transcript, Michael Irwig talks with Diabetes in Control publisher Steve Freed during the AACE 2018 convention in Boston about treating low testosterone and how diabetes and obesity can affect testosterone levels.Read More »